A new European hub of reference for biotech companies, the Madrid region combines scientific excellence, cutting-edge infrastructure, and an attractive business environment. A must-have destination for industry stakeholders looking for the ideal place to expand internationally.
As German biotech firms look for new international growth opportunities, Madrid stands out with a combination of assets rarely found elsewhere in Europe: a dense network of high-level research centers, a proactive innovation strategy, and an integrated hospital system that facilitates clinical trials.
A structured and connected scientific environment
The region is home to over 400 companies in the health and biotech sectors, providing 24,000 direct jobs and hosting 39 production sites. Global industry leaders engage in activities that go far beyond distribution – including R&D, manufacturing, and healthcare services. This density fosters ongoing synergies between major pharmaceutical groups, innovative startups, hospitals, and public research institutions such as CNIO (Spanish National Cancer Research Centre), CSIC, Carlos III Health Institute, and the upcoming National Centre for Neurotechnology.
Infrastructure dedicated to research and innovation
Madrid hosts eight science and technology parks, 13 singular scientific and technical infrastructures (ICTS), and 13 biomedical research foundations. These facilities create a favorable environment for the establishment and growth of innovative companies, closely connected to universities and local competitiveness clusters.
A Human-scale region with strong Public-Private partnerships
What truly sets Madrid apart from many other European hubs is its ability to combine institutional proximity with operational agility. Company leaders find clear points of contact who can facilitate access to hospitals, universities, and technological platforms. Regional policies in health and biotech are built on long-term co-development with economic stakeholders, including public calls for collaborative projects in breakthrough technologies, preclinical research, and biofabrication.
A growing pool of biotech talent
Beyond headline figures on graduates, the Madrid region stands out for the alignment of its training programs with the specific needs of the biotech sector. We are seeing rapid growth in:
- Training in regulatory affairs, clinical trials, and medical affairs
- Specializations in health-focused data science
- Hands-on programs in biopharmaceutical manufacturing and quality
From technical schools to universities and health cluster partnerships, Madrid is building a talent pipeline tailored to the needs of expanding companies, while facilitating mobility across the European space.
A leading region for clinical trials
Thanks to the close integration of research, industry, and healthcare systems, Spain is now the leading country in Europe for clinical trials, with Madrid playing a central role. A decisive advantage for German biotech firms developing new treatments and seeking large-scale validation environments.
Madrid is far more than a strategic gateway – it’s a living ecosystem that supports companies at every stage of their biotech development.